We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$2.76B
AUM Growth
-$525M
Cap. Flow
-$439M
Cap. Flow %
-15.9%
Top 10 Hldgs %
38.29%
Holding
343
New
69
Increased
54
Reduced
100
Closed
111

Top Buys

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$17.9M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$17.3M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$14.1M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$14M
5
CUTR
Cutera, Inc.
CUTR
+$12.7M

Top Sells

Rank Stock Value
1
SEER icon
Seer Inc
SEER
+$24.7M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.4M
3
LIVN icon
LivaNova
LIVN
+$20.2M
4
GKOS icon
Glaukos
GKOS
+$17.5M
5
COO icon
Cooper Companies
COO
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.75%
2 Consumer Staples 0.58%
3 Financials 0.5%
4 Consumer Discretionary 0.42%
5 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTH
301
Faeth Therapeutics
FTH
$757M
– –
-1,130
Closed -$238K
SOPH icon
302
SOPHiA GENETICS
SOPH
$635M
– –
-450,010
Closed -$7.89M
TBPH icon
303
CALL
Theravance Biopharma
TBPH
$878M
– –
-100,000
Closed -$740K
TBPH icon
304
Theravance Biopharma
TBPH
$878M
– –
-100,000
Closed -$740K
TDOC icon
305
PUT
Teladoc Health
TDOC
$1.22B
– –
-220,000
Closed -$27.9M
TNDM icon
306
PUT
Tandem Diabetes Care
TNDM
$1.63B
– –
-100,000
Closed -$11.9M
TPB icon
307
Turning Point Brands
TPB
$1.73B
– –
-91,449
Closed -$4.37M
UNH icon
308
PUT
UnitedHealth
UNH
$364B
– –
-85,000
Closed -$33.2M
VEEV icon
309
PUT
Veeva Systems
VEEV
$39.2B
– –
-50,000
Closed -$14.4M
WBA
310
PUT
DELISTED
Walgreens Boots Alliance
WBA
– –
-150,000
Closed -$7.06M
WST icon
311
PUT
West Pharmaceutical
WST
$24.8B
– –
-20,000
Closed -$8.49M
XENE icon
312
PUT
Xenon Pharmaceuticals
XENE
$6.31B
– –
-50,000
Closed -$764K
ZBH icon
313
Zimmer Biomet
ZBH
$18.7B
– –
-66,950
Closed -$9.51M
ZTS icon
314
PUT
Zoetis
ZTS
$30.4B
– –
-60,000
Closed -$11.6M
TRAW icon
315
Traws Pharma
TRAW
$8.12M
– –
-6,000
Closed -$575K
NVRO
316
CALL
DELISTED
NEVRO CORP.
NVRO
– –
-80,000
Closed -$9.31M
NVRO
317
DELISTED
NEVRO CORP.
NVRO
– –
-10,000
Closed -$1.16M
ITCI
318
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-52,213
Closed -$1.95M
RCM
319
DELISTED
R1 RCM Inc. Common Stock
RCM
– –
-300,000
Closed -$6.6M
OLK
320
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-362,746
Closed -$8.94M
SWAV
321
PUT
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-47,500
Closed -$9.78M
CANO
322
CALL
DELISTED
Cano Health, Inc.
CANO
– –
-2,000
Closed -$2.54M
CANO
323
DELISTED
Cano Health, Inc.
CANO
– –
-12,750
Closed -$16.2M
THRN
324
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
– –
-200,000
Closed -$1.73M
AMRS
325
DELISTED
Amyris Inc.
AMRS
– –
-1,275,096
Closed -$11.9M
10 11 12
13
14

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Pura Vida Investments held 343 positions worth $2.76B, down 16% from $3.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments withdrew a net $439M in Q4 2021, closing 111 positions and reducing 100 holdings. Its most notable exit was Seer Inc, an estimated $24.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Pura Vida Investments opened a new position in BioMarin Pharmaceuticals worth $15M.

  • Pura Vida Investments's largest Q4 2021 buy was BioMarin Pharmaceuticals: 170,210 shares worth $15M.
  • Pura Vida Investments added most to ViewRay, Inc. in Q4 2021, an estimated $17.9M increase.
  • Pura Vida Investments's biggest Q4 2021 reduction was LivaNova, cutting an estimated $20.2M.
  • Pura Vida Investments fully exited Seer Inc in Q4 2021, selling an estimated $24.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $2.76B portfolio in Q4 2021.
  • Pura Vida Investments opened 69 new positions and closed 111 in Q4 2021.
  • Pura Vida Investments's portfolio value fell 16% quarter-over-quarter to $2.76B.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.